Biotech Startups

Provides biomedical testing services focused on gut microbiome analysis combined with personalized probiotic treatments to address common urban health issues. The company bases its approach on genetic testing and proprietary probiotic formulations tailored to individual needs.

1 investor

BioMed Central is an academic publisher of open access, peer-reviewed scientific journals, including titles such as Algorithms for Molecular Biology covering bioinformatics and molecular biology research. It serves researchers and academics across biology, medicine, and related life-science fields.

1 investor

BiomEdit develops microbiome-based products for animal health using high-throughput microbiology and AI-powered predictive algorithms. The company applies synthetic biology techniques to modify microbial populations for therapeutic and agricultural applications.

1 investor

1 investor

bioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.

1 investor

Biomerix (a biomedical division of dsm-firmenich) develops and co-creates biomaterials used in implantable medical devices, working with medical device and pharmaceutical companies worldwide. It provides customized biomaterial solutions along with co-development, quality, and regulatory support services.

1 investor

Biomine Health is South Africa's microbiome testing and treatment company, providing personalized health insights based on microbiome analysis to help people understand and optimize their gut health. The company serves individuals seeking proactive health management through microbiome-based diagnostics and treatments.

1 investor

Biomm is a Brazilian biotechnology company that develops and commercializes medicines for people with chronic diseases, with a focus on expanding access to healthcare in Brazil. It also aims to increase the country's domestic production autonomy within the pharmaceutical industry.

1 investor

BioModAI provides an autonomous AI agent that designs molecular biology assays, primers, CRISPR guides, and DNA constructs for research and biotech teams. The agent runs real bioinformatics tools on actual genomic data and delivers publication-ready reports with full audit trails, typically within hours.

1 investor

Bionamic provides a spreadsheet-based platform for annotating and profiling antibody and molecule developability, turning raw sequences into workbook records with features like numbering, PTM motifs, CDR ranges, and developability predictions (immunogenicity, solubility, aggregation propensity). It serves biotech and drug discovery teams working on molecule profiling and decision-making.

1 investor

Bio Natural Solutions develops biotech products from agricultural waste for crop protection and food preservation, serving agribusiness and food industry customers.

1 investor

Bioneer develops molecular biology products including magnetic bead-based mRNA purification using Oligo(dT), multiplex target analysis, and cell-free protein synthesis and purification systems. Its offerings serve life science research and laboratory workflows in the biotechnology sector.

1 investor

Bioness Medical develops neuromodulation, robotic, and software-based medical technologies for patients with central nervous system disorders and orthopedic injuries. The company's products serve healthcare providers seeking to improve patient outcomes and operational efficiency.

1 investor

Bionic Sight develops gene therapy treatments for inherited blindness conditions, leveraging expertise in optogenetics and viral vector delivery to restore vision in patients with retinitis pigmentosa and geographic atrophy.

1 investor

Bionity.com is a German-language B2B trade portal for the life sciences, biotechnology, and pharmaceutical industries, offering news, trends, supplier directories, job listings, and lab and production solutions. Operated by LUMITOS AG, it serves professionals in industry, research, and science and provides online marketing services to reach this B2B audience.

1 investor

Peptide therapeutics for immuno-inflammatory diseases and cancer (acquired).

1 investor

Bionomous builds automated precision sorting systems for small round biological entities (roughly 500 μm to 2 mm), such as fish embryos, 3D cell models, aquaculture samples, and plant seeds. Its products serve research labs and industrial operations seeking to automate repetitive manual sorting and standardize quality control.

1 investor

BioNorth Solutions is a green biotechnology company that develops and produces strains of bacteria and microbial biosurfactant products for hydrocarbon remediation, industrial contaminant remediation, soil revitalization, and land reclamation. Founded in 2014, it serves environmental, industrial, and agricultural clients across North and South America.

1 investor

Bionote develops animal-health and diagnostic products, including rapid immunodiagnostic tests, fluorescent and enzyme immunoassays, molecular diagnostics, and vaccines. It operates in the veterinary/biotech diagnostics industry.

1 investor

Bionova Medical develops Foundation DRS Solo, a biodegradable, collagen-free chitosan-glycosaminoglycan dermal regeneration scaffold for advanced wound care. The device is intended to promote healing of full and partial thickness wounds, ulcers, burns, surgical wounds, and other skin injuries.

1 investor

Bionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.

1 investor

Bionure Investment is a company based in Barcelona focused on developing solutions for neurodegenerative diseases affecting patients worldwide. The organization operates in the biotech and digital health sectors.

1 investor

Biopallo is a Finnish company built around a biological/microbiological process technology, with a team including process and technology experts and microbiologists. The page presents company management and board members but does not detail the specific product or end market.

1 investor

Biopharm is a pharmaceutical company founded in 1992 that manufactures and distributes medications and medical devices in Algeria. The company serves the Algerian healthcare market and is a major player in the country's pharmaceutical industry.

1 investor